Your browser doesn't support javascript.
loading
Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa.
Kantele, Anu; Riekkinen, Marianna; Jokiranta, T Sakari; Pakkanen, Sari H; Pietilä, Jukka-Pekka; Patjas, Anu; Eriksson, Mari; Khawaja, Tamim; Klemets, Peter; Marttinen, Kati; Siikamäki, Heli; Lundgren, Anna; Holmgren, Jan; Lissmats, Agneta; Carlin, Nils; Svennerholm, Ann-Mari.
Afiliación
  • Kantele A; Meilahti Vaccine Research Center, MeVac, University of Helsinki and Department of Infectious Diseases, Inflammation Center, HUS, Helsinki University Hospital, Helsinki, Finland.
  • Riekkinen M; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.
  • Jokiranta TS; Travel Clinic, Aava Medical Center, Helsinki, Finland.
  • Pakkanen SH; Meilahti Vaccine Research Center, MeVac, University of Helsinki and Department of Infectious Diseases, Inflammation Center, HUS, Helsinki University Hospital, Helsinki, Finland.
  • Pietilä JP; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.
  • Patjas A; Travel Clinic, Aava Medical Center, Helsinki, Finland.
  • Eriksson M; United Medix Laboratories/Synlab Finland Ltd, Helsinki, Finland.
  • Khawaja T; Medicum, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
  • Klemets P; Mobidiag Ltd, Espoo, Finland.
  • Marttinen K; Meilahti Vaccine Research Center, MeVac, University of Helsinki and Department of Infectious Diseases, Inflammation Center, HUS, Helsinki University Hospital, Helsinki, Finland.
  • Siikamäki H; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.
  • Lundgren A; Meilahti Vaccine Research Center, MeVac, University of Helsinki and Department of Infectious Diseases, Inflammation Center, HUS, Helsinki University Hospital, Helsinki, Finland.
  • Holmgren J; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.
  • Lissmats A; Travel Clinic, Aava Medical Center, Helsinki, Finland.
  • Carlin N; Meilahti Vaccine Research Center, MeVac, University of Helsinki and Department of Infectious Diseases, Inflammation Center, HUS, Helsinki University Hospital, Helsinki, Finland.
  • Svennerholm AM; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.
J Travel Med ; 30(7)2023 11 18.
Article en En | MEDLINE | ID: mdl-37099803
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Escherichia coli Enterotoxigénica Tipo de estudio: Clinical_trials Límite: Child / Humans País/Región como asunto: Africa / Europa Idioma: En Revista: J Travel Med Asunto de la revista: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Escherichia coli Enterotoxigénica Tipo de estudio: Clinical_trials Límite: Child / Humans País/Región como asunto: Africa / Europa Idioma: En Revista: J Travel Med Asunto de la revista: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Año: 2023 Tipo del documento: Article País de afiliación: Finlandia